NQO1 and metabolic dysfunction-associated steatotic liver disease: Although NQO1 is not as studied in the field of MASLD, the studies that have been conducted to date have shown varying results regarding the expression and/or activity of this enzyme in MASLD/MASH patients as well as in many MASLD/MASH animal or cell models (Table S6).